Full Text View
Tabular View
Study Results
Related Studies
Glimepiride 4 mg Tablets Under Non-Fasting Conditions
This study has been completed.
Study NCT00835172   Information provided by Teva Pharmaceuticals USA

First Received on January 30, 2009.   Last Updated on September 1, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Healthy
Interventions listed in this trial
Glimepiride 4 mg Tablets
AMARYL® 4 mg Tablets
Additional drug interventions recognized in this trial
Glimepiride
More general drug interventions related to this trial
Anti-Arrhythmia Agents
Cardiovascular Agents
Hypoglycemic Agents
Immunologic Factors
Immunosuppressive Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Teva Pharmaceuticals USA


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services